09:13 AM EDT, 04/03/2025 (MT Newswires) -- Health care stocks were leaning lower premarket Thursday, with The Health Care Select Sector SPDR Fund ( XLV ) down 0.7% and the iShares Biotechnology ETF (IBB) was 2.2% lower.

RxSight ( RXST ) shares were down past 32% after the company lowered its 2025 revenue guidance range to between $160 million and $175 million from its previous projection of $185 million to $197 million.

Aveanna Healthcare ( AVAH ) shares were more than 5% lower after the company said it has agreed to acquire Thrive Skilled Pediatric Care, a pediatric home healthcare company.

Novartis ( NVS ) shares were up over 3% after the company said overnight that the US Food and Drug Administration granted accelerated approval for Vanrafia to reduce proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapid disease progression.